The upregulated expression of 5-LOX and 12-LOX have been identified in colon, prostate, breast, and pancreas cancers and associated with tumor cell proliferation, migration, and worsened prognosis [25,26,27,28,29]. This evidence concerns the gene ALOX5 and neoplasm.